Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:03 AM
Study NCT ID:
NCT00003079
Status:
COMPLETED
Last Update Posted:
2010-02-17
First Post:
2000-05-02
Brief Title:
Bryostatin 1 and High Dose Cytarabine in Treating Patients With Refractory or Relapsed Leukemia or Lymphoma
Sponsor:
Virginia Commonwealth University
Organization:
Virginia Commonwealth University
Organization Data
Organization:
Virginia Commonwealth University
Class:
OTHER
Study ID:
CDR0000065773
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Virginia Commonwealth University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
National Cancer Institute
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |